Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Yoga for Executives Who Can’t Touch Their Toes No Incense, No Chanting –– Just 2021 Stress-Relief


Designed for high powered professionals who cannot touch their toes, Executive Yoga offers maximum stress reduction with minimal time investment: less than 12 minutes a day over 8 weeks.

EXECUTIVE YOGA is an 8-week course designed around the schedules of busy executives even if they can’t touch their toes.

“There’s no incense or chanting,” says Edward Vilga “only the most effective stretching, breathing, and stress-reduction. And, as we transition from 2020 to 2021, never before has this been more needed.”

The American Psychological Association reports that with COVID-19 and the economy, more than 7 in 10 Americans are reporting significantly higher stress than in 2019. In fact, according to the National Endowment for Financial Education, in April 2020 nearly 9 in 10 Americans reported feeling stressed about their financial futures. The American Psychological Association even states that “We are facing a national mental health crisis that could yield serious health and social consequences for years to come.”

“There’s so much data that yoga can help with wellness and stress reduction,” says Edward Vilga who has been teaching yoga for over 20 years. “Harvard Medical School published a report in October 2020 saying that ‘the scientific study of yoga demonstrates that mental and physical health are not just closely allied, but are essentially equivalent. The evidence is growing that yoga practice is a relatively low-risk, high-yield approach to improving overall health.’”

Features and benefits of EXECUTIVE YOGA include:

  • Designed for beginners, this program is accessible for almost any fitness level
  • It offers online group lessons with Q&A as well as a weekly 1:1 private lesson
  • Students receive daily reminders of poses to practice
  • The entire program averages only 12 minutes a day.

“Those of us who’ve tried yoga are almost always sold on its benefits. Therefore, I designed this as the perfect gift for the high-powered professional who has everything––except enough time and peace of mind!”

Edward Vilga’s EXECUTIVE YOGA’s first session begins on January 2, 2021. Enrollment is $2497. For more information, visit http://www.ExecutiveYoga.Fit.

About Edward Vilga: Edward Vilga has over 50,000 students in his online courses. He has created 17 bestselling wellness books, DVDs, and courses and has reached #1 on Amazon for both Wellness and New Thought. His work has been translated into over a dozen languages. His yoga DVDs have been viewed and downloaded over a million times.

Share article on social media or email:

Baymark Health Services Acquires Pennsylvania Opioid Treatment Program


Earlier efforts to alleviate the opioid epidemic had begun to produce results with counties across Pennsylvania reporting up to 50% decreases in overdose deaths since 2018.

BayMark Health Services announced the acquisition of Echo Treatment Center, an opioid treatment provider in Washington, Pennsylvania. Echo Treatment provides outpatient medication-assisted treatment (MAT) utilizing methadone and substance abuse counseling and education. The facility will fall under BayMark’s MedMark Treatment Centers brand.

Providing a broad continuum of care for the treatment of substance use disorders, BayMark is an established, trusted provider of comprehensive addiction treatment. Since 2016, Echo Treatment has shared the same focus on providing high-quality treatment for those in need in the greater Pittsburgh area.

In addition to methadone maintenance treatment (MMT) and counseling, services will also include addiction and relapse education, coordinated treatment during pregnancy, in-house lab services and referrals to community resources to assist patients in rebuilding their lives. Methadone, combined with counseling and support services, is known as the gold standard in the treatment of opioid addiction.

“Earlier efforts to alleviate the opioid epidemic had begun to produce results with counties across Pennsylvania reporting up to 50% decreases in overdose deaths since 2018. All of that changed as the opioid crisis intersected with the Covid-19 pandemic this year,” noted David K. White, Ph.D., Chief Executive Officer of BayMark Health Services. “Overdose deaths are back up across the state, as high as 30% in some areas such as Beaver County with spikes up to 75% in others. Many counties are reporting deaths on track to reach or exceed 2017 high-water marks. It’s clear that treatment options are urgently needed. BayMark has acquired or partnered with 9 programs in Central and Western Pennsylvania since January and will utilize our expertise to improve accessibility in a safe and effective environment.”

Medication-assisted treatment reduces the symptoms of opioid withdrawal and cravings, allowing patients to focus on the underlying causes of their addiction and support them as they develop new, healthier coping mechanisms. Opioid treatment programs offer a proven alternative to residential or abstinence-based treatment models for Opioid Use Disorder.

For more information on BayMark Health Services, or to find a location near you, visit BayMark.com.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to 62,000+ patients in recovery from substance use disorders across the United States and Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances.

The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.

Share article on social media or email:

Society for Immunotherapy of Cancer Publishes Clinical Practice Guideline on Immune Effector Cell-related Adverse Events


“This is the tenth manuscript published in SITC’s Cancer Immunotherapy Guidelines series, a critically important effort to educate physicians and other health care providers, and improve outcomes for cancer patients receiving FDA-approved immunotherapies,” said SITC President Mario Sznol, MD.

The Society for Immunotherapy of Cancer (SITC), the world’s leading member-driven organization dedicated solely to cancer immunotherapy, is pleased to announce the publication of a clinical practice guideline for the management of cell therapy adverse events. Immune effector cell therapies include the three U.S. Food and Drug Administration (FDA)-approved chimeric antigen receptor (CAR) T cell products for treatment of blood-based cancers.

“The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events,” was published in the Journal for ImmunoTherapy of Cancer (JITC) and is part of the society’s long running Cancer Immunotherapy Guidelines program. The guideline was developed by an expert panel of physicians representing multiple medical specialties, patient advocates, and nurses. It covers risk-assessment, identification and management for the most clinically significant side effects associated with immune effector cell therapies.

“Immune effector cell therapies, especially the CAR T cell products, have increasingly become an integral component of cancer care for patients with hematologic (blood-based) malignancies,” said Stephan Grupp, MD, PhD, co-chair of the SITC Immune Effector Cell-Related Adverse Events Expert Panel. “It’s crucial for oncologists and hematologists to understand the toxicities that may arise after treatment with these agents, so that they may safely offer these potentially lifesaving therapies to patients.”

Immune effector cells are made from a patient’s own cells or in some cases from cells taken from a donor, usually from the blood. When these immune effector cells are infused back into a patient, they become “living drugs” that expand and persist in the body to attack cancer cells. This is one reason why immune effector cell therapies can sometimes produce long-lasting disease control, with some patients remaining cancer free for years after treatment. However, the therapies may cause unique side effects which can be similar to severe infections.

“Clinicians need to feel comfortable identifying the signs and symptoms of common adverse events such as cytokine release syndrome and neurotoxicity so that they can appropriately intervene,” said Marcela Maus, MD, PhD, co-chair of the SITC Immune Effector Cell-Related Adverse Events Expert Panel. “In many cases, the adverse events associated with immune effector cell therapies may be safely managed, but prompt recognition is crucial.”

The SITC Cancer Immunotherapy Guidelines were developed by leading experts to help hematologists and oncologists determine when and how to best use immunotherapy to treat their patients. The published disease-state specific guidelines provide evidence- and expert consensus-based recommendations on selection of appropriate immunotherapy treatments, toxicity management, biomarkers, and considerations for patient quality of life. SITC has published clinical practice guidelines for acute leukemia, bladder carcinoma, cutaneous melanoma, head and neck squamous cell carcinoma, multiple myeloma, non-small cell lung cancer, prostate cancer and renal cell carcinoma. Additional guidelines in development will cover lymphoma, breast cancer, hepatocellular carcinoma, non-melanoma skin cancer and immune checkpoint inhibitor-related adverse events.

“Cell therapy is one of the major advances in cancer treatment in the past decade, and it’s reasonable to expect more of these cell therapies to be developed, and to see their use extend beyond very specialized treatment centers. SITC recognized the growing importance and use of cell therapy and therefore developed this new clinical practice guideline to assist physicians with management of the unique side effects,” said SITC President Mario Sznol, MD. “This is the tenth manuscript published in SITC’s Cancer Immunotherapy Guidelines series, a critically important effort to educate physicians and other health care providers, and improve outcomes for cancer patients receiving FDA-approved immunotherapies.”

SITC is a proponent for collaboration and harmonization of efforts between like-minded organizations whenever possible. SITC wishes to thank the American Society of Hematology (ASH), the American Society for Transplantation and Cellular Therapy (ASTCT), the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center, and the Emily Whitehead Foundation for providing representatives to serve on SITC’s Immune Effector Cell-related Adverse Events Expert Panel to aid in the development of this clinical practice guideline.

In addition to the published manuscript, SITC is also offering several different opportunities to help clinicians understand and implement the guidelines into their practice, including the live webinars and on-demand modules hosted on the SITC website. In 2021, SITC will host a live, free webinar during which attendees will be able to learn more about the recommendations included in this clinical practice guideline and ask questions of expert faculty. Registration information will be available in the coming weeks.

About SITC

Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.

About JITC

Journal for ImmunoTherapy of Cancer (JITC) is the official open access, peer-reviewed online journal of the Society for Immunotherapy of Cancer featuring an impact factor of 10.252. The journal publishes high-quality articles on all aspects of tumor immunology and cancer immunotherapy, on subjects across the basic science-translational-clinical spectrum. JITC publishes original research articles, literature reviews, position papers and practice guidelines, and case reports; invited commentaries may also be commissioned by the journal editors. These articles, freely accessible at jitc.bmj.com, make JITC the leading forum for tumor immunology and cancer immunotherapy research. Follow JITC on Twitter @jitcancer.

# # #

Share article on social media or email:



Team Novo Nordisk Confirms 17-Rider Roster For 2021 Season


All athletes on Team Novo Nordisk race with diabetes. Its 2021 roster features 17 riders from 12 different countries.

“2021 is a year we’ve had our sights on for some time, and we are proud and honored to celebrate 100 years of life for people with diabetes on a global scale,” Team Novo Nordisk CEO and Co-Founder Phil Southerland said.

Team Novo Nordisk, the world’s first all-diabetes professional cycling team, confirmed its 2021 roster complete with 17 riders from 12 different countries, including two new signings moving up from its development team.

Coming out of what has been an unprecedented year for the world, Team Novo Nordisk is eager to shift focus to 2021 where the onus will be on celebrating the 100th year anniversary of the discovery of insulin, meaning life for people with diabetes. The yearlong celebration is extra meaningful to Team Novo Nordisk’s title sponsor, Novo Nordisk, since its inception in 1923, has remained focused on defeating diabetes by pioneering innovative medicines.

“Aside from Covid-19, 2020 has been a pretty stellar year. For our organization, the biggest highlight was Novo Nordisk extending our partnership through 2023. We are incredibly proud to have such an amazing partner to continue changing diabetes for the world,” Team Novo Nordisk CEO and Co-Founder Phil Southerland said. “We saw tremendous progress within our pipeline, including our biggest Talent ID camp in the team’s history. The development team had a great year of growth and success and the pro team made a solid step forward in confidence.”

All athletes on Team Novo Nordisk race with diabetes. This unique distinction means that the team’s foundation makes it feel like a family and many riders remain with the organization for their entire professional careers.

After only 40 race days across 12 races due to Covid-19, Team Novo Nordisk started focusing on 2021 early and quickly moved to sign new riders Lucas Dauge (FRA) and Logan Phippen (USA) from the development team and extend with team veterans David Lozano (ESP), Andrea Peron (ITA), Charles Planet, and former Hungarian champion Peter Kusztor, who joined the organization in 2019.

“What a difficult, stressful, and strange year, but I feel the entire organization stepped up as strong ambassadors for the diabetes community. Throughout the year, we focused our attention on keeping everyone safe while still figuring out creative ways to keep sharing the team’s mission to inspire, educate and empower everyone affected by diabetes,” Team Novo Nordisk General Manager Vassili Davidenko said. “I am proud to say that all our major sponsors stayed with us through this difficult time. We are incredibly grateful for each and every one of them. Now we are eager to move on to 2021 and hopefully it will include more consistent racing!

Before travel restrictions went into effect, Team Novo Nordisk kicked off the 2020 season by securing numerous top 10s at the International Rhodes Tour. Following the racing hiatus, the team returned to racing with a seventh-place finish at the Circuito de Getxo by Planet. In late August, Lozano wore the King of the Mountain’s jersey for multiple stages at the Tour de Hongrie.

“We started strong in Greece, with three different riders taking top 10s, and after lockdown, watching Charles return with a top 10 in Spain was huge. But I would say the team effort at the Tour de Hongrie was my highlight of the year,” Southerland explained. ”The guys rode their hearts out to keep David in the red jersey, which was only lost on the final stage through a tiebreaker. It is that passion and hunger that makes me so proud of this team.”

Building on the positives will be key for 2021 and what will be a landmark year for the team and the global diabetes community.

“2021 is a year we’ve had our sights on for some time, and we are proud and honored to celebrate 100 years of life for people with diabetes on a global scale. We do not take our roles lightly and we are driven to keep showing the world what is possible when you take control of your diabetes thanks to the lifesaving invention that is insulin,” Southerland concluded. “We look forward to leveraging the added layer of visibility this brings to the project to show how far the world of diabetes has come and to keep inspiring the next generation of heroes out there living with the condition.”

Team Novo Nordisk’s Men’s Professional Roster for the 2021 season:


  • Hamish Beadle – NZL
  • Oliver Behringer – SUI
  • Mehdi Benhamouda – FRA
  • Sam Brand – GBR
  • Stephen Clancy – IRL
  • Lucas Dauge – FRA
  • Gerd de Keijzer – NED
  • Joonas Henttala – FIN
  • Declan Irvine – AUS
  • Brian Kamstra – NED
  • Peter Kusztor – HUN
  • David Lozano – ESP
  • Sam Munday – AUS
  • Andrea Peron – ITA
  • Logan Phippen – USA
  • Charles Planet – FRA
  • Umberto Poli – ITA

About Team Novo Nordisk

Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world’s first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

# # #

Media Contact:

Fitzalan Crowe for Team Novo Nordisk

Fitzalan.crowe@teamnovonordisk.com

+1-703-596-2020

Share article on social media or email:

HealthLeaders is excited to announce the launch of a new technology e-newsletter


Healthcare IT plays an essential role in delivering the resources and solutions required to meet the needs of all stakeholders in a healthcare system.

The healthcare industry has experienced rapid change in 2020. This year has not only presented a new set of challenges for hospitals and health systems but also led to growth and new opportunities in technology. Simultaneously, demand has increased to provide crucial data to healthcare executives to help them make timely strategic decisions.

In response to these changes, HealthLeaders is excited to announce the launch of a new e-newsletter publication delivering weekly news and analysis in technology.

“Healthcare IT plays an essential role in delivering the resources and solutions required to meet the needs of all stakeholders in a hospital or health system,” says Erika Randall, Content Manager at HealthLeaders.

Even before the COVID-19 pandemic and the explosive growth of telehealth, IT and technology leaders played an important role in deploying new approaches to provide quality care. This includes artificial intelligence (AI), predictive analytics, and other technologies, all while handling increasing IT challenges such as interoperability, data security, and privacy issues.

Randall adds, “While providers are working hard on the front lines, there are tremendous efforts happening behind the scenes to provide them with the tools they need to deliver care in new ways. The advancements in healthcare technology are one of the triumphs of the pandemic.”

The editorial team at HealthLeaders is committed to keeping executives informed about developments and trends in the healthcare industry. In September 2020, we launched a bimonthly e-newsletter, Telehealth, in response to rapid innovation and implementation of telemedicine and connected health initiatives.

“We hope that by sharing this information, we can connect our readers to the people and resources that matter, putting them in a better position to accelerate their strategic initiatives,” says Randall.

Our new technology e-newsletter is focused on sharing success stories from hospitals and health systems, as well as exposing healthcare executives to emerging technologies. To learn more about the technology e-newsletter and other HealthLeaders publications, visit https://interactive.healthleadersmedia.com/subscribe.

###

About HealthLeaders

HealthLeaders is a multiplatform media company dedicated to serving over 300,000 healthcare executives and professionals in key functional areas such as credentialing, compliance, CDI, nursing, revenue cycle, quality, safety, and more at ambulatory, acute, and post acute care facilities. It offers an extensive and integrated series of leadership publications, products, research, and events devoted to the business of health care, including a magazine, e-newsletters, executive roundtables, webcasts, and more. Visit https://www.healthleadersmedia.com.

Share article on social media or email:

ZRT Laboratory’s Dried Blood Spot (DBS) COVID-19 IgG Antibody Testing Methodology and Validation Published in a Peer-Reviewed Journal


“As the COVID-19 vaccine rollout begins there will be an increased need for identifying a successful vaccine-stimulated immune antibody response to the SARS-CoV-2 spike protein, which is made possible with the ZRT DBS COVID-19 IgG S1 Spike Antibody Test.” – Theodore Zava

The modification of two commercially available COVID-19 IgG antibody assays for use with capillary finger stick dried blood spots (DBS) was successfully validated and published in the peer-reviewed journal Future Science – Bioanalysis. The clinical comparison study between DBS and serum, which had Institutional Review Board (IRB) approval, is the most comprehensive analysis related to DBS COVID-19 antibody testing to date.

A total of 177 matching DBS and serum samples were analyzed and showed 100% positive and 99.3% negative concordance between serum run according to manufacturer instructions and the ZRT DBS COVID-19 IgG S1 Spike Antibody Test, and 100% positive and 98% negative concordance between serum run according to manufacturer instructions and the ZRT DBS COVID-19 IgG Nucleocapsid Antibody Test. ZRT DBS COVID -19 IgG S1 Spike and Nucleocapsid assay validation included precision, hematocrit effect, interference, hook effect, drying and shipping conditions, blood spot size and punch location, dry time, and filter paper lot comparisons.

The use of DBS allows for a health care professional assisted finger stick collection in place of a venous blood draw, and the potential for at-home collection. DBS are easy to collect, transport, and store for future use. As the COVID-19 vaccine rollout begins there will be an increased need for identifying a successful vaccine-stimulated immune antibody response to the SARS-CoV-2 spike protein, which is made possible with the ZRT DBS COVID-19 IgG S1 Spike Antibody Test. The ZRT DBS COVID-19 IgG S1 Spike and Nucleocapsid assays can also detect an immune response from a native COVID-19 infection.

Currently the ZRT DBS COVID-19 IgG S1 Spike Antibody Test is available for commercial use, while the ZRT DBS COVID-19 IgG S1 Spike and Nucleocapsid Antibody Test combination is available for research use only. ZRT Laboratory submitted data to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) in October for the ZRT DBS COVID-19 IgG S1 Spike Antibody Test.

ZRT Laboratory is a CLIA-certified high complexity testing facility that offers a wide range of dried blood spot, dried urine, saliva, and serum testing. With over 10 million clinical tests performed over the past 20+ years, coupled with our signature personalized test report, ZRT Laboratory has become a world recognized leader in hormone and wellness testing. Individuals, health care providers in all 50 states and in over 100 countries, as well as research-oriented government, private, and academic organizations worldwide use our testing. Learn more at http://www.zrtlab.com.

Share article on social media or email:

Little Steps Announces Upcoming Move to New Glenview Location


Little Steps Pediatric Therapy logo.

We’re excited to move to the new clinic and give our patients and therapists more space.

Little Steps Pediatric Therapy has announced plans to move in February 2021 from their original Glenview, Illinois location at 41 B Waukegan Rd. to a temporary location at 1864 Johns Dr. Soon after that, in spring 2021, the care provider will transition to another more permanent space in Glenview.

The permanent new Glenview site – measuring 4,400 sq. ft. – will give the provider’s team of pediatric professionals more room to treat patients and offer specialized programs, such as Little Steps’ Enrichment Pods designed to help Pre-K through 5th-grade students with reading, speech, handwriting and other capabilities.    

“The old location was great, but we’ve outgrown it,” said Jaime Passaglia, founder of Little Steps. “We’re excited to move to the new clinic and give our patients and therapists more space.”

The move is the latest development in the provider’s expansion as Passaglia and her team seek to serve as many children as possible. In October 2020, they opened a new Little Steps location in Willowbrook, Illinois, which followed the launch of another Glenview site at 1850 Johns Dr. in September. Additionally, Passaglia created a sister company, Little Steps Florida LLC., in August after team member Erica Vitaliano, a pediatric speech therapist, moved there.

To better serve patients in the Chicago area, the pediatric therapy provider also maintains clinics in Highland Park, Wilmette and the city of Chicago. With a focus on comprehensive and compassionate care, they specialize in pediatric physical therapy, speech therapy and occupational therapy to improve the lives of their patients one step at a time.

If you’d like to learn more about Little Steps, their locations and the services they offer, please call 847-707-6744 or email info@littlestepspt.com.

About Little Steps

Little Steps Pediatric Therapy is a privately-owned company composed of pediatric professionals focused on delivering physical therapy, speech therapy and occupational therapy to children of all ages. To reach as many patients as possible, we provide therapeutic treatment from clinics in Chicago, Glenview, Highland Park, Wilmette and Willowbrook – in addition to extending our services beyond the Chicago area via our sister company, Little Steps Florida LLC. Our team is determined to provide comprehensive and educational care to change the lives of children one step at a time. To learn more, visit littlestepspt.com.

For more information contact:

Kaley Rosinski

847-707-6744

info@littlestepspt.com

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Santa Barbara


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Santa Barbara, CA for 2021. The informational guide recognizes the top 14 rehab facilities based on cost, treatment options, location, accompanying services, and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Santa Barbara, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Santa Barbara with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Santa Barbara. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Santa Barbara, CA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-santa-barbara-ca/

2021 Best Rehab Facilities in Santa Barbara, CA (in alphabetical order)

Aegis Treatment Centers Santa Barbara

4129 State Street

Santa Barbara, CA 93110

805-964-4795

CADA-Council on Alcoholism and Drug Abuse

232 East Canon Perdido Street

Santa Barbara, CA 93101

805-963-1433

Casa Serena Treatment Programs for Women

1515 Bath Street

Santa Barbara, CA 93101

805-966-1260

Channel Islands Rehab

145 Santa Rosa Avenue

Oxnard, CA 93035

800-675-7963

Cottage Residential Center

316 West Montecito Street

Santa Barbara, CA 93101

805-569-7422

Evolve Santa Barbara Outpatient Treatment

1029 State Street

Santa Barbara, CA 93101

424-33201446

Good Heart Recovery Outpatient Rehab

205 West Mission Street

Santa Barbara, CA 93101

805-919-8918

Mission Harbor Behavioral Health

403 East Montecito Street, Suite A

Santa Barbara, CA 93101

805-209-4446

Narconon Ojai

9950 Sulphur Road

Ojai, CA 93023

877-475-0079

Pure Recovery California, Inc.

4310 Tradewinds Drive STE 300

Oxnard, CA 93035

800-714-0340

Recovery Ranch LLC

3694 B. Tivola Street

Santa Ynez, CA 93460

805-705-0766

Recovery Road Medical Center

334 South Patterson, Suite 120

Santa Barbara, CA 93111

805-962-7800

Santa Barbara New House, Inc.

2434 Bath Street

Santa Barbara, CA 93105

805-563-6050

The Salvation Army Santa Barbara

4849 Hollister Avenue

Santa Barbara, CA 93111

805-964-8738

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Huntington Beach


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Huntington Beach, CA for 2021. The informational guide recognizes the top 23 rehab facilities based on cost, treatment options, location, accompanying services, and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Huntington Beach, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Huntington Beach with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Huntington Beach. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Huntington Beach, CA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-huntington-beach-ca/

2021 Best Rehab Facilities in Huntington Beach, CA (in alphabetical order)

AKUA Mind and Body

20271 SW Birch Street, Suite 200

Newport Beach, CA 92660

888-737-1712

Anchored Tides Recovery

19126 Magnolia Street, Suite 101

Huntington Beach, CA 92646

714-377-7706

Beachview Treatment

602 Geneva Avenue

Huntington Beach, CA 92648

949-614-0391

Broadway Treatment Center

18582 Beach Boulevard, Suite 214

Huntington Beach, CA 92648

714-443-8218

Buckeye Recovery Network

19322 Beach Boulevard

Huntington Beach, CA 92648

Phone: 888-604-6446

Casa Capri Recovery

4001 Westerly Place, Suite 110

Newport Beach, CA 92660

844-593-8020

Clear Life Recovery

2822 Monterey Avenue

Costa Mesa, CA 92626

844-443-0251

Couples Rehabs

18582 Beach Boulevard, Suite 214

Huntington Beach, CA 92648

844-904-6653

Dee’s House

18886 Santa Maria Street

Fountain Valley, CA 92708

714-374-6873

Get Real Recovery

30290 Rancho Viejo Road, Suite 204

San Juan Capistrano, CA, 92675

714-401-5904

Hired Power

21062 Brookhurst Street, #201

Huntington Beach, CA 92646

714-615-0155

Hoag

One Hoag Drive

Newport Beach, CA 92648

800-400-4624

Hotel California By The Sea

2811 Villa Way

Newport Beach, CA 92663

800-762-6717

Morningside Recovery

5904-A Warner Avenue, #241

Huntington Beach, CA 92649

855-416-8202

Orange County Recovery

18632 Beach Boulevard, #240

Huntington Beach, CA 92648

866-227-1437

R&R Recovery at Seacliff

18682 Beach Boulevard, #225

Huntington Beach, CA 92648

714-364-0720

Resurgence Behavioral Health

3151 Airway Avenue H2

Costa Mesa, CA 92626

888-700-5053

Simple Recovery

1901 Newport Boulevard, #200

Costa Mesa, CA 92627

888-743-0490

Surf City Recovery

18090 Beach Boulevard, Suite 5

Huntington Beach, CA 92648

714-841-3868

The District Recovery Community

19671 Beach Blvd #430

Huntington Beach, CA 92648

844-287-8506

True Recovery

20351 SW Acacia Street, Floor 2

Newport Beach, CA 92660

866-384-6847

Wavelengths Recovery

301 Main Street, Suite 201

Huntington Beach, CA 92648

888-958-2068

Windward Way Recovery

3822 Campus Drive

Newport Beach CA 92660

855-491-7694

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

SPOL Releases Holiday COVID Public Service Announcement


“We’re all so close to receiving our COVID vaccine, we just to keep on observing safety protocols for just a little longer,.”

Watch SPOL PSA Video Here

Strategic Planning Online, SPOL, like most companies, has navigated the challenges of COVID-19 this year by shifting all but three of its employees to work from home status. Throughout the year, SPOL team members have endured having many friends and family suffer, and in some cases pass on, from the virus. Despite knowing the dangers of and safeguards against COVID, one SPOL team member contracted the virus in August. SPOL’s Chief Operating Officer, Ed Clougherty, delivered a large sub sandwich to Josh, SPOL’s Digital Media Manager, while he was isolating from his family at home and going through the illness. A smiling Josh watched from a second story window as his COO placed the food on his front porch. Thankfully, Josh recovered, and his family remained safe and well.

A month or so after recovery, Josh and Clougherty were talking about how Josh caught the virus, and how easy it was to let one’s guard down against this unrelenting threat. Struck by the passion and firm beliefs in COVID safeguards that Josh communicated, Clougherty brought the conversation up at SPOL’s weekly VP meeting. Listening to the conversation, SPOL’s founder and CEO, Andrew Davies, directed his staff to consider creating a public service announcement (PSA) reminding all of the continued importance of observing COVID safety protocols.

“We’re all so close to receiving our COVID vaccine, and we felt that people needed a gentle reminder to keep on observing COVID safety protocols for just a little longer,” said Chief Revenue Officer Margarita Santiler. She suggested the some of the children of SPOL team members participate in the PSA video, and a script quickly followed.

“SPOL is blessed with a diverse staff with immense talents that can quickly come together to turn a concept into a finished product in a remarkably short period of time.” CEO Davies commented. “We hope people not only watch the video, but also forward it to their loved ones, colleagues, and friends. The simple steps outlined in the video will save countless people from the ravages that COVID can wreak. We wish all a happy and safe holiday season, and hope to have all with us around for the holidays of next year and beyond.”

About SPOL

SPOL helps colleges and universities improve institutional effectiveness and better prepare students for success. The company’s integrated software platform encompasses planning, budgeting, assessment, program review, credentialing, and accreditation.

For more information, visit https://spol.com.

Share article on social media or email: